Increasing evidence suggested a regulatory role of TGF‐β1/Smad signalling in the p‐glycoprotein mediated multidrug resistance11, 12 and the tumour microenvironment driven cancer progression.5, 21. This evidence concerns the gene TGFB1 and neoplasm.